Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients
- PMID: 2057005
- DOI: 10.1002/mds.870060210
Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients
Abstract
In a double-blind, placebo-controlled study, 23 patients suffering from intractable spasmodic torticollis (ST) were given successively either botulinum toxin A (BTA) or normal saline by intramuscular injections in the affected muscles. Evaluation was carried out by three blinded observers, using a clinical and video assessment of the severity of torticollis, employing a scoring system described by Tsui (1). Patients were also asked to subjectively comment on changes in the amount of pain and on changes in the activities of daily living (ADL). BTA was proven to be superior on all forms of assessment to placebo, and these results were statistically significant. Side effects mainly consisted of pain at the injection site. Tiredness occurred at equal frequency with BTA and placebo. No serious or systemic side effects were noted. Botulinum toxin is a safe, effective and relatively simple treatment for spasmodic torticollis.
Similar articles
-
[Torticollis treated with botulinum toxin].Ugeskr Laeger. 1993 Feb 1;155(5):284-9. Ugeskr Laeger. 1993. PMID: 8446996 Danish.
-
BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).Mov Disord. 1997 Sep;12(5):772-5. doi: 10.1002/mds.870120526. Mov Disord. 1997. PMID: 9380065
-
Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.J Med Assoc Thai. 1994 Sep;77(9):464-70. J Med Assoc Thai. 1994. PMID: 7706965
-
Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia.J Formos Med Assoc. 1995 Apr;94(4):189-92. J Formos Med Assoc. 1995. PMID: 7606182 Review.
-
Botulinum A toxin in spasmodic torticollis.Ann Pharmacother. 1992 Feb;26(2):216-7. Ann Pharmacother. 1992. PMID: 1554937 Review. No abstract available.
Cited by
-
Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.Ital J Neurol Sci. 1997 Oct;18(5):261-9. doi: 10.1007/BF02083302. Ital J Neurol Sci. 1997. PMID: 9412849 Review.
-
Botulinum toxin type A therapy for cervical dystonia.Cochrane Database Syst Rev. 2020 Nov 12;11(11):CD003633. doi: 10.1002/14651858.CD003633.pub4. Cochrane Database Syst Rev. 2020. PMID: 33180963 Free PMC article.
-
Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.J Neurol Neurosurg Psychiatry. 1995 Dec;59(6):601-7. doi: 10.1136/jnnp.59.6.601. J Neurol Neurosurg Psychiatry. 1995. PMID: 7500097 Free PMC article. Clinical Trial.
-
Vibro-tactile stimulation of the neck reduces pain in people with cervical dystonia: a proof-of-concept study.Neurol Sci. 2024 Oct;45(10):4847-4856. doi: 10.1007/s10072-024-07561-1. Epub 2024 May 11. Neurol Sci. 2024. PMID: 38730131 Free PMC article.
-
Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.CNS Drugs. 2008;22(9):725-38. doi: 10.2165/00023210-200822090-00002. CNS Drugs. 2008. PMID: 18698873 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources